We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

LabCorp® and Duke University Collaborate to Offer Genomic Tests

The program will support advanced research studies in specified clinical testing applications in genomic medicine.
News

Clinical Data Announces Launch of Genetic Test for Warfarin Response

Company licenses intellectual property relating to genetic testing for warfarin response.
News

OHSU Cancer Institute Study Points to Future of Personalized Medicine

Scientists discover that patients responded differently to the targeted therapy Sunitinib depending on the type of genetic abnormality in their cancer.
News

Researchers Present Advances in Prostate Cancer Program

Markers discovered that may aid in the prediction of recurrence of prostate cancer.
News

Personalized Treatment Trial for Breast Cancer Launched

This trial is important because it is one of the first to examine a methodology for personalizing cancer treatment.
News

FDA Grants Biovest International Fast Track Status for BiovaxID™

Biovest is now eligible to submit a biologics license application (BLA) on a rolling basis.
News

Clinical Development Program Utilizing Xenomics' DNA-Based Diagnostic Technology is Ranked Best in Europe

European Consortium led By Xenomics' collaborative venture with leading European research center prepares for euro 2 million funding of tuberculosis clinical program.
News

RCP Diagnostics Licenses Its Protein Marker to Biomarker Technologies

Biomarker will use the RCP marker only for the diagnosis of breast cancer.
News

J. Brian Munroe Elected President and Chairman of Personalized Medicine Coalition

Newly appointed vice president of WellPoint brings important payer constituency into coalition.
News

GeneGo and XB TransMed Provide Integrated Solutions to the Translational Medicine Market

XB-BIS integration with the MetaCore™ permits the user to integrate back and forth between expanding knowledge and enhanced application.
Advertisement